Theranos : how did a $9 billion health tech startup end up DOA? / Ernesto Dal Bó, Guo Xu.

Stanford University drop-out Elizabeth Holmes hoped to disrupt the traditional $75 billion blood-testing business with only one drop from a finger prick instead of several vials of blood. The revolutionary claim of Theranos' founder was that her groundbreaking technology enabled a full range of...

Full description

Bibliographic Details

Online Access:	Full Text (via SAGE)
Main Authors:	Dal Bó, Ernesto (Author), Xu, Guo, active 2020 (Author)
Other title:	Theranos : how did a $9 billion health tech startup end up dead on arrival.
Format:	eBook
Language:	English
Published:	London : The Berkeley-Haas Case Series. University of California, Berkeley. Haas School of Business, 2021.
Series:	SAGE Business. Cases.
Subjects:	Theranos (Firm) > Case studies. Medical technology > Case studies. Fraud > Case studies. Theranos (Firm) Fraud. Medical technology. Case studies.